"전남대학교병원은 1910년 광주 자혜의원으로 개원한 이래 오랜 전통을 가지고 호남의 중추적인 환자중심 병원으로 발전하여 왔습니다. 2004년에는 화순전남대학교병원을 개원하여 새로운 시대가 요구하는 각종 암 관련 질환과 만성질환에 대한 전문진료센터를 운영하여 국민을 위한 종합병원으로서의 역할을 수행하고 있습니다."

During the past decade, Chonnam National University Hospital conducted 177 clinical trials. In the 10-year time frame, 177 clinical trials started and 58 clinical trials were completed, i.e. on average, 32.8% percent of trials that started reached the finish line to date. In the past 5 years, 72 clinical trials started and 42 clinical trials were completed. i.e. 58.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Chonnam National University Hospital" #1 sponsor was "Seung-Jung Park" with 33 trials, followed by "Chonnam National University Hospital" with 23 trials sponsored, "Pfizer" with 19 trials sponsored, "Boehringer Ingelheim" with 14 trials sponsored and "Janssen Research & Development, LLC" with 14 trials sponsored. Other sponsors include 151 different institutions and companies that sponsored additional 98 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Chonnam National University Hospital" #1 collaborator was "CardioVascular Research Foundation, Korea" with 38 trials as a collaborator, "Chonnam National University Hospital" with 8 trials as a collaborator, "Abbott" with 6 trials as a collaborator, "Chosun University Hospital" with 4 trials as a collaborator and "Kyungpook National University Hospital" with 4 trials as a collaborator. Other collaborators include 141 different institutions and companies that were collaborators in the rest 115 trials.

According to Clinical.Site data, the most researched conditions in "Chonnam National University Hospital" are "Coronary Artery Disease" (35 trials), "Rheumatoid Arthritis" (13 trials), "Schizophrenia" (9 trials), "Atrial Fibrillation" (8 trials) and "Acute Myocardial Infarction" (7 trials). Many other conditions were trialed in "Chonnam National University Hospital" in a lesser frequency.

Most popular intervention types in "Chonnam National University Hospital" are "Drug" (161 trials), "Device" (39 trials), "Procedure" (25 trials), "Biological" (19 trials) and "Other" (18 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (56 trials), "Percutaneous coronary intervention" (4 trials), "Aspirin" (3 trials), "Fimasartan" (3 trials) and "placebo" (3 trials). Other intervention names were less common.

The vast majority of trials in "Chonnam National University Hospital" are 252 trials for "All" genders, 6 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Chonnam National University Hospital". undefined are not yet recruiting, 46 are recruiting, 29 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 125 completed trials in Chonnam National University Hospital, undefined suspended trials, and 28 terminated clinical trials to date.

Out of the total trials that were conducted in Chonnam National University Hospital, 7 "Phase 1" clinical trials were conducted, 33 "Phase 2" clinical trials and 89 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 45 trials, and there were also 29 trials that are defined as “Not Applicable".

Chonnam National University Hospital has several departments that took part in Clinical trials: "Department of Neurology, Chonnam National University Hospital" - 4 trials